Zhongjing Wanxi Secures Market Access to North America: A New Milestone in Global Expansion

Zhongjing Wanxi Pharmaceutical Co., Ltd. recently achieved a major breakthrough in its internationalization strategy. Led by local partners in Canada, ten of the company’s core products—including Tian Zhi Granules, Tong Jing Bao Granules, and Liu Wei Di Huang Pills—have officially completed registration as Natural Health Products in Canada. This success grants the products a “passport” to enter the mainstream North American pharmaceutical market, marking a pivotal step for Zhongjing Wanxi’s international strategy and laying a solid foundation for classic Traditional Chinese Medicine (TCM) formulas to be integrated into the global healthcare system.

 Rooted in the hometown of the “Medicine Sage” Zhang Zhongjing, Zhongjing Wanxi is a modern enterprise dedicated to the inheritance and innovation of TCM. Adhering to the core philosophy that “CHOICE HERBS, CHOICE MEDICINE” the company has built an integrated health ecosystem encompassing manufacturing, agriculture, commerce, food, medical services, wellness, and public health. By leveraging authentic TCM herb cultivation bases and modern pharmaceutical technologies, Zhongjing Wanxi is driving the transformation of ancient classic formulas toward modernization and internationalization. 

The 10 successfully registered products are all core varieties with definite clinical efficacy and excellent market reputation, covering tonification, tranquillization, physical conditioning and other fields, which precisely meet North American people’s demand for natural health products.

Notably, Tian Zhi Granules, a state-level new drug independently developed by Zhongjing Wanxi, has shown significant efficacy in improving mild-to-moderate vascular dementia, offering a brand-new TCM solution for brain health in the North American market.

Canada possesses one of the world’s most mature regulatory systems for natural health products, with stringent standards regarding safety, efficacy, quality control, and labeling. Meeting these requirements serves as a crucial benchmark for TCM to enter the mainstream North American market. 

Through collaboration with local Canadian partners, Zhongjing Wanxi leveraged their deep understanding of North American regulatory policies and market rules to efficiently navigate the entire registration process. From raw material traceability and formula compliance verification to production standard alignment, submission of safety and efficacy data, and localized labeling, the company strictly adhered to the Natural Health Product Regulations of Health Canada. The successful approval not only underscores the high quality of Zhongjing Wanxi’s products but also ensures their precise alignment with international market standards.

Looking ahead, Zhongjing Wanxi aims to use this successful registration in Canada as a catalyst to further deepen its collaboration with local partners and accelerate the commercial launch and promotion of these products across the Canadian market. Simultaneously, the company will ramp up efforts in the international registration and R&D of more classic TCM formulas. By continuously empowering traditional medicine with modern technology, Zhongjing Wanxi remains committed to uncovering the scientific essence of classic prescriptions and communicating the therapeutic value of TCM in an international context. This mission is driven by a desire to facilitate the full integration of TCM into the global healthcare system, ultimately showcasing the timeless appeal and universal value of traditional Chinese medicine.